Published in J Adv Res on February 23, 2016
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem (1974) 15.45
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
Anemia of chronic disease. N Engl J Med (2005) 10.88
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta (1978) 6.95
Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res (1997) 6.33
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant (2004) 4.27
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis (2007) 3.96
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78
Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis (2003) 2.17
The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin (2004) 2.16
Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrol Dial Transplant (2011) 1.80
Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant (2005) 1.61
Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant (2004) 1.30
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol (2008) 1.30
Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int (2004) 1.18
Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest (2009) 1.14
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. NDT Plus (2009) 1.09
Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.06
Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients. Clin Nephrol (2003) 1.03
A simple colorimetric method for ascorbic acid determination in blood plasma. Clin Chim Acta (1978) 1.03
Redox regulation in the extracellular environment. Circ J (2008) 1.02
Inflammation and resistance to treatment with recombinant human erythropoietin. J Ren Nutr (2005) 1.01
Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. J Am Soc Nephrol (2002) 1.00
Inflammation and resistance to erythropoiesis-stimulating agents--what do we know and what needs to be clarified? Nephrol Dial Transplant (2005) 0.91
Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am J Health Syst Pharm (2007) 0.89
Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol (2008) 0.89
Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. Nephrology (Carlton) (2005) 0.89
A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant (2006) 0.88
The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study. Biol Trace Elem Res (2010) 0.86
Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press Res (2003) 0.86
Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease? Nat Clin Pract Nephrol (2008) 0.86
The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients. BMC Nephrol (2011) 0.86
Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol Dial Transplant (1999) 0.86
An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chim Acta (2002) 0.86
[Effect of oxidative stress in patients with chronic renal failure]. Nefrologia (2006) 0.85
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol (2008) 0.85
Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial (2001) 0.85
IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency. Hemodial Int (2012) 0.84
Health-related quality of life in the era of erythropoietin. Hemodial Int (2008) 0.83
Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm (2003) 0.83
Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine. Immunology (2001) 0.82
Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis (2001) 0.81
Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients. Saudi J Kidney Dis Transpl (2012) 0.80
Serum albumin fragmentation in end-stage renal disease patients--a pilot study. Clin Chem Lab Med (2009) 0.78
[C-reactive protein in the assessment of iron status in patients on hemodialysis]. G Ital Nefrol (2009) 0.78
Oxidation parameters in complete correction of renal anemia. Clin Nephrol (2000) 0.77
Effects of hemodialysis period on levels of blood trace elements and oxidative stress. Clin Exp Nephrol (2010) 0.77
Application of the thiobarbiturate assay to the measurement of lipid peroxidation products in microsomes. J Biochem Biophys Methods (1986) 0.76
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis. Ther Clin Risk Manag (2009) 0.76
Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study. BMC Nephrol (2009) 0.76